Surgery – Diagnostic testing – Measuring or detecting nonradioactive constituent of body...
Reexamination Certificate
2006-11-17
2011-12-13
Winakur, Eric (Department: 3777)
Surgery
Diagnostic testing
Measuring or detecting nonradioactive constituent of body...
C600S476000
Reexamination Certificate
active
08078243
ABSTRACT:
A method of determining a measure of a tissue state (e.g., glycation end-product or disease state) in an individual. A portion of the tissue of the individual is illuminated with excitation light, then light emitted by the tissue due to fluorescence of a chemical with the tissue responsive to the excitation light is detected. The detected light can be combined with a model relating fluorescence with a measure of tissue state to determine a tissue state. The invention can comprise single wavelength excitation light, scanning of excitation light (illuminating the tissue at a plurality of wavelengths), detection at a single wavelength, scanning of detection wavelengths (detecting emitted light at a plurality of wavelengths), and combinations thereof. The invention also can comprise correction techniques that reduce determination errors due to detection of light other than that from fluorescence of a chemical in the tissue. For example, the reflectance of the tissue can lead to errors if appropriate correction is not employed. The invention can also comprise a variety of models relating fluorescence to a measure of tissue state, including a variety of methods for generating such models. Other biologic information can be used in combination with the fluorescence properties to aid in the determination of a measure of tissue state. The invention also comprises apparatuses suitable for carrying out the method, including appropriate light sources, detectors, and models (for example, implemented on computers) used to relate detected fluorescence and a measure of tissue state.
REFERENCES:
patent: 4094609 (1978-06-01), Fujii et al.
patent: 4653880 (1987-03-01), Sting et al.
patent: 4655225 (1987-04-01), Dahne et al.
patent: 4661706 (1987-04-01), Messerschmidt et al.
patent: 4684255 (1987-08-01), Ford
patent: 4712912 (1987-12-01), Messerschmidt
patent: 4730882 (1988-03-01), Messerschmidt
patent: 4853542 (1989-08-01), Milosevic et al.
patent: 4857735 (1989-08-01), Noller
patent: 4859064 (1989-08-01), Messerschmidt et al.
patent: 4867557 (1989-09-01), Takatani et al.
patent: 4882492 (1989-11-01), Schlager
patent: 4883351 (1989-11-01), Weiss
patent: 4883953 (1989-11-01), Koashi et al.
patent: 4895159 (1990-01-01), Weiss
patent: 4975581 (1990-12-01), Robinson et al.
patent: 5007423 (1991-04-01), Branstetter et al.
patent: 5419323 (1995-05-01), Kittrell et al.
patent: 5582168 (1996-12-01), Samuels et al.
patent: 5601079 (1997-02-01), Wong et al.
patent: 5754716 (1998-05-01), Kim et al.
patent: 5935062 (1999-08-01), Messerschmidt et al.
patent: 6070093 (2000-05-01), Oosta et al.
patent: 6088606 (2000-07-01), Ignotz et al.
patent: 6124597 (2000-09-01), Shehada et al.
patent: 6201989 (2001-03-01), Whitehead et al.
patent: 6230034 (2001-05-01), Messerschmidt et al.
patent: 6332092 (2001-12-01), Deckert et al.
patent: 6505059 (2003-01-01), Kollias
patent: 6537211 (2003-03-01), Wang et al.
patent: 6571118 (2003-05-01), Utzinger et al.
patent: 6574490 (2003-06-01), Abbink et al.
patent: 6622033 (2003-09-01), Messerschmidt et al.
patent: 6684099 (2004-01-01), Ridder et al.
patent: 6862091 (2005-03-01), Johnson
patent: 6865408 (2005-03-01), Abbink et al.
patent: 7039446 (2006-05-01), Ruchti et al.
patent: 7139598 (2006-11-01), Hull et al.
patent: 2001/0039483 (2001-11-01), Brand et al.
patent: 2001/0046045 (2001-11-01), Dong et al.
patent: 2002/0010401 (2002-01-01), Bushmakin et al.
patent: 2002/0016534 (2002-02-01), Trepagnier et al.
patent: 2002/0082487 (2002-06-01), Kollias et al.
patent: 2002/0091324 (2002-07-01), Kollias et al.
patent: 2003/0013973 (2003-01-01), Georgakoudi et al.
patent: 2003/0195401 (2003-10-01), Tian et al.
patent: 2004/0068193 (2004-04-01), Barnes et al.
patent: 2004/0092822 (2004-05-01), Robinson et al.
patent: 2004/0114211 (2004-06-01), Trepagnier et al.
patent: 2005/0131304 (2005-06-01), Stamatas et al.
patent: 2005/0203355 (2005-09-01), Stamatas et al.
patent: 2006/0089556 (2006-04-01), Bambot et al.
patent: 2006/0094942 (2006-05-01), Winther
patent: 2006/0149143 (2006-07-01), Colvin
patent: 2006/0195022 (2006-08-01), Trepagnier et al.
Ediger MN, Fleming CM, Rohrscheib M, Way JF, Nguyen CM and Maynard JD: Noninvasive Fluorescence Spectroscopy for Diabetes Screening: A Clinical Case-Control Study (Abstract). Diabetes Technology Meeting, San Francisco, CA, Nov. 11, 2005.
Hull EL, Ediger MN, Unione AHT, Deemer EK, Stroman ML and Baynes JW: Noninvasive, optical detection of diabetes: model studies with porcine skin. Optics Express 12:4496-4510, 2004.
Engelgau MM, Narayan KM, Herman WH: Screening for Type 2 diabetes. Diabetes Care 23:1563-1580, 2000.
http://www.diagnoptics.com/index.php?cat=products&page=publications, visited Feb. 26, 2007.
R. Meerwaldt; R. Graaff; P. H. N. Oomen; T. P. Links; J. J. Jager; N. L. Alderson; S. R. Thorpe; J. W. Baynes; R. O. B. Gans; A. J. Smit. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia (2004) 47:1324-1330.
Helen L. Lutgers, MD; Reindert Graaff, MSC, PhD; Thera P. Links, MD, PhD; Lielith J. Ubink-Veltmaat, MD, PhD; Henk J. Bilo, Md, Phd; Rijk O. Gans, MD, PhD; Andries J. Smit, MD, PhD. Skin Autofluorescence as a Noninvasive Marker of Vascular Damage in Patients With Type 2 Diabetes. Diabetes Care, vol. 29, No. 12, Dec. 2006.
Douwe J. Mulder, M.D.; Tara Van De Water, M.Sc.; Helen L. Lutgers, M.D.; Reindert Graaff, M.Sc., Ph.D.; Rijk O. Gans, M.D., Ph.D.; Felix Zijlstra, M.D., Ph.D.; and Andries J. Smit, M.D., Ph.D. Skin Autofluorescence, a Novel Marker for Glycemic and Oxidative Stress-Derived Advanced Glycation Endproducts: An Overview of Current Clinical Studies, Evidence, and Limitations. Diabetes Technology & Therapeutics vol. 8, No. 5, 2006.
Robbert Meerwaldt, MD, PhD; Helen L. Lutgers, MD; Thera P. Links, MD, PhD; Reindert Graaff, MSC, PhD; John W. Baynes, Phd; Rijk O.B. Gans, MD, PhD; Andries J. Smit, MD, PhD. Skin Autofluorescence Is a Strong Predictor of Cardiac Mortality in Diabetes. Diabetes Care, vol. 30, No. 1, Jan. 2007.
Ediger et al. Detecting Type 2 Diabetes with Noninvasive Skin Fluorescence Spectroscopy. Fifth Annual Diabetes Technology Meeting. Nov. 11, 2005.
Ediger MN, Fleming CM, Rohrscheib M, Way JF, Nguyen CM and Maynard JD: Noninvasive Fluorescence Spectroscopy for Diabetes Screening: A Clinical Case-Control Study (poster). Diabetes Technology Meeting, San Francisco, CA, Nov. 11, 2005.
C.D. Brown, Ph.D., H.T. Davis, Ph.D., M.N. Ediger, Ph.D.,,* C.M. Fleming, Ph.D., E.L. Hull, Ph.D., and M. Rohrscheib, M.D. Clinical Assessment of Near-Infrared Spectroscopy for Noninvasive Diabetes Screening. Diabetes Technology & Therapeutics. vol. 7, No. 3, 2005.
Brown Christopher D
Ediger Marwood Neal
Hull Edward L
Johnson Robert D
Maynard John D
Grafe V. Gerald
VeraLight, Inc.
Winakur Eric
LandOfFree
Determination of a measure of a glycation end-product or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Determination of a measure of a glycation end-product or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Determination of a measure of a glycation end-product or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4305121